Nuo Therapeutics Inc  

(Public, OTCMKTS:NUOT)   Watch this stock  
Find more results for OTC:CMXI
0.330
0.000 (-0.06%)
Dec 24 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.30 - 0.33
52 week 0.27 - 0.67
Open 0.32
Vol / Avg. 125,990.00/320,265.00
Mkt cap 41.03M
P/E     -
Div/yield     -
EPS -0.23
Shares 124.41M
Beta -1.11
Inst. own 3%
Nov 14, 2014
Q3 2014 Cytomedix Inc Earnings Call
Nov 13, 2014
Q3 2014 Cytomedix Inc Earnings Release
  

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -282.83% -174.99%
Operating margin -265.79% -156.38%
EBITD margin - -133.44%
Return on average assets -30.57% -44.71%
Return on average equity -132.89% -62.48%
Employees 40 -
CDP Score - -

Address

207a Perry Pkwy Ste 1
GAITHERSBURG, MD 20877-2196
United States - Map
+1-240-4992680 (Phone)
+1-302-5313150 (Fax)

Website links

Description

Nuo Therapeutics, Inc., formerly Cytomedix, Inc., is a regenerative therapies company marketing and developing products within the United States and internationally. The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company is a commercial operation, and a robust clinical pipeline representing a logical extension of its commercial technologies in the evolving field of regenerative medicine. Nuo Therapeutics, Inc. primarily operates in the United States. Its commercial offerings are centered on its point of care platform technologies for the safe and efficient separation of blood and bone marrow to produce platelet based therapies or cell concentrates.

Officers and directors

David Emerson Jorden CPA Executive Chairman of the Board
Age: 51
Martin P. Rosendale Chief Executive Officer, Director
Age: 56
Steven S. Shallcross CPA Chief Financial Officer, Executive Vice President, Treasurer, Secretary
Age: 52
Peter A. Clausen Ph.D. Chief Science Officer
Dean Tozer Chief Commercial Officer
Lyle A. Hohnke Ph.D. Director
Age: 70
Joseph Del Guercio Independent Director
Age: 41
Stephen N. Keith M.D. Independent Director
Richard S. Kent M.D. Independent Director
Age: 64
Mark T. McLoughlin Independent Director
Age: 58